“Identification of Nafamostat and VR23 as COVID-19 drug candidates by targeting 3CLpro and PLpro"-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

“Identification of Nafamostat and VR23 as COVID-19 drug candidates by targeting 3CLpro and PLpro"

Published:2021-06 Issue: Volume:1233 Page:130094
ISSN:0022-2860
Container-title:Journal of Molecular Structure
language:en
Short-container-title:Journal of Molecular Structure

Author:

Bhowmik Deep,Sharma Ravi Datta,Prakash Amresh,Kumar Diwakar

Funder

Department of Biotechnology

Science and Engineering Research Board

Publisher

Elsevier BV

Subject

Inorganic Chemistry,Organic Chemistry,Spectroscopy,Analytical Chemistry

Reference80 articles.

1. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers;Abraham;SoftwareX,2015

2. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs;Anand;Science,2003

3. Pharmacological studies of FUT-175, nafamstatmesilate. I. Inhibition of protease activity in in vitro and in vivo experiments;Aoyama;Jpn. J. Pharmacol.,1984

4. Potential inhibitorsagainst papain-like protease of novel coronavirus (SARS-CoV-2) from FDA approved drugs;Arya;ChemRxiv.Preprint,2020

5. Potential of heparin and nafamostat combination therapy for COVID-19;Asakura;Journal of thrombosis and haemostasis: JTH,2020

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the potential of Psidium guajava derived phytoconstituents as anticholinesterase inhibitor to combat Alzheimer’s disease: an in-silico and in-vitro approach;Journal of Biomolecular Structure and Dynamics;2024-01-11

2. Drug repurposing for the treatment of COVID-19: Targeting nafamostat to the lungs by a liposomal delivery system;Journal of Controlled Release;2023-12

3. Computational insights into pediatric adenovirus inhibitors:in silicostrategies for drug repurposing;Journal of Biomolecular Structure and Dynamics;2023-08-29

4. A Narrative Review: Molecular Docking Simulation of Antiviral Drugs as Anti-COVID-19 Candidates;Research Journal of Pharmacy and Technology;2023-06-26

5. Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal;Journal of Biomedical Science;2022-09-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3